HK1034044A1 - Fat-binding polymers - Google Patents

Fat-binding polymers

Info

Publication number
HK1034044A1
HK1034044A1 HK01104514A HK01104514A HK1034044A1 HK 1034044 A1 HK1034044 A1 HK 1034044A1 HK 01104514 A HK01104514 A HK 01104514A HK 01104514 A HK01104514 A HK 01104514A HK 1034044 A1 HK1034044 A1 HK 1034044A1
Authority
HK
Hong Kong
Prior art keywords
fat
polymers
binding polymers
binding
methods
Prior art date
Application number
HK01104514A
Other languages
English (en)
Inventor
W Harry Mandeville Iii
George M Whitesides
Stephen Randall Holmes-Farley
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/166,453 external-priority patent/US6264937B1/en
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of HK1034044A1 publication Critical patent/HK1034044A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Detergent Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
HK01104514A 1998-01-09 2001-06-29 Fat-binding polymers HK1034044A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US496398A 1998-01-09 1998-01-09
US09/166,453 US6264937B1 (en) 1998-01-09 1998-10-05 Fat-binding polymers
PCT/US1999/000028 WO1999034787A2 (en) 1998-01-09 1999-01-04 Fat-binding polymers

Publications (1)

Publication Number Publication Date
HK1034044A1 true HK1034044A1 (en) 2001-10-12

Family

ID=26673719

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104514A HK1034044A1 (en) 1998-01-09 2001-06-29 Fat-binding polymers

Country Status (19)

Country Link
EP (1) EP1043981B1 (es)
JP (1) JP2002500183A (es)
KR (2) KR100773625B1 (es)
CN (1) CN1212123C (es)
AT (1) ATE237349T1 (es)
AU (2) AU740233B2 (es)
BR (1) BR9907234A (es)
CA (1) CA2318417A1 (es)
DE (1) DE69906928T2 (es)
ES (1) ES2200493T3 (es)
HK (1) HK1034044A1 (es)
HU (1) HUP0100890A3 (es)
IL (1) IL137096A (es)
MX (1) MX222446B (es)
NO (1) NO20003510L (es)
NZ (2) NZ523301A (es)
PL (1) PL193452B1 (es)
RU (1) RU2222335C2 (es)
WO (1) WO1999034787A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267952B1 (en) * 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
EP1196181A1 (en) * 1999-07-14 2002-04-17 Geltex Pharmaceuticals, Inc. Fat-binding polymers, optionally combined with lipase inhibitors
AU7447600A (en) * 1999-10-01 2001-05-10 Amato Pharmaceutical Products, Ltd. Antiobestic agents
PL204443B1 (pl) 2000-07-28 2010-01-29 Hoffmann La Roche Kompozycja farmaceutyczna zawierająca inhibitor lipazy, sposób wytwarzania kompozycji farmaceutycznej, zestaw do leczenia otyłości, zastosowanie kompozycji farmaceutycznej oraz zastosowanie orlistatu i substancji wiążącej kwasy żółciowe
MXPA03009562A (es) * 2001-04-18 2004-02-12 Genzyme Corp METODO PARA TRATAR EL SiNDROME X CON POLIAMINAS ALIFATICAS.
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
SE0302253D0 (sv) * 2003-08-21 2003-08-21 Forskarpatent I Syd Ab Lipase-colipase inhibitor
CN106176800B (zh) * 2016-07-11 2019-12-06 韩源平 多聚阳离子树脂的制药应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7017227A (es) * 1969-12-27 1971-06-29
US4211765A (en) * 1971-10-12 1980-07-08 Monsanto Company Method for controlling obesity
US4432968A (en) * 1980-10-20 1984-02-21 The Dow Chemical Company Weight control with fat imbibing polymers
AU7653081A (en) * 1980-10-20 1982-04-29 Dow Chemical Company, The T-butylstyrene copolymers for controlling body weight of animals
JPH02503205A (ja) * 1988-02-12 1990-10-04 ドゥ　ツァープフェル，ブリギット 医用及びパラメディカル用の架橋親水性コポリマー
JP3507523B2 (ja) * 1993-05-12 2004-03-15 積水化学工業株式会社 糖質吸収抑制剤

Also Published As

Publication number Publication date
WO1999034787A3 (en) 2000-01-20
PL343898A1 (en) 2001-09-10
DE69906928T2 (de) 2004-02-19
KR100773625B1 (ko) 2007-11-05
HUP0100890A3 (en) 2001-12-28
HUP0100890A2 (hu) 2001-08-28
NO20003510L (no) 2000-09-07
NZ505294A (en) 2003-02-28
NZ523301A (en) 2005-11-25
PL193452B1 (pl) 2007-02-28
BR9907234A (pt) 2000-10-10
KR20060111741A (ko) 2006-10-27
IL137096A0 (en) 2001-06-14
MXPA00006681A (es) 2001-02-01
EP1043981B1 (en) 2003-04-16
ES2200493T3 (es) 2004-03-01
AU1950599A (en) 1999-07-26
AU740233B2 (en) 2001-11-01
CN1212123C (zh) 2005-07-27
NO20003510D0 (no) 2000-07-07
CA2318417A1 (en) 1999-07-15
ATE237349T1 (en) 2003-05-15
RU2222335C2 (ru) 2004-01-27
EP1043981A2 (en) 2000-10-18
KR20010034013A (ko) 2001-04-25
WO1999034787A2 (en) 1999-07-15
IL137096A (en) 2006-10-31
MX222446B (en) 2004-09-01
DE69906928D1 (de) 2003-05-22
CN1288381A (zh) 2001-03-21
AU2002014755A1 (en) 2002-03-14
JP2002500183A (ja) 2002-01-08

Similar Documents

Publication Publication Date Title
EP0831832A4 (en) METHODS FOR CONTROLLING INFECTIOUS DISEASES USING DICATIONIC BIS-BENZIMIDAZOLES
CA2334267A1 (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
UA88270C2 (ru) Фармацевтический препарат и его применение для профилактики удара, диабета
EP1736152A3 (en) Physiologically stable compositions of butyric acid as well as butyric acid salts and derivatives for treating wounds
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
EP1702618A3 (en) Compositions and uses of et743 in combination therapy for treating cancer
NO990934L (no) Anvendelse av arakidonsyre og/eller dokosaheksansyre for fremstilling av et medikament for behandling av dyspraksi
EP0957925A4 (en) TREATMENT OF OSTEOARTHRITIS BY ADMINISTRATION OF POLY-N-ACETYL-D-GLUCOSAMINE
ATE237349T1 (en) Fat-binding polymers
WO2001005408A8 (en) Fat-binding polymers, optionally combined with lipase inhibitors
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
GB0020504D0 (en) Therapeutic method
EP0699444A3 (en) Composition for the treatment of intestinal wounds or ulcers containing proteins, carbohydrates and fat
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
SE9902597D0 (sv) New use
CZ223199A3 (cs) Použití inhibitorů COMT nebo jejich farmaceuticky vhodných solí nebo esterů pro výrobu léčiva k prevenci diabetických vaskulárních dysfunkcí
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
WO2002076393A3 (en) Antiagionecic, antitumor, chemopreventative agents
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
MD1469F1 (en) Method of treatment of the burn shock
EP1512413A3 (en) Pharmaceutical combination containing a 4-quinazolineamine and another anti-neoplastic agent for the treatment of cancer
WO2000023058A3 (en) Use of an antianaerobic-bacterial or/and antiprotozoal agent (preferably metronidazole) in the manufacture of a medicament for the treatment of haemorrhoids
UA28928A (uk) Спосіб лікування гнійно-запальних захворювань м'яких тканин
UA37346A (uk) Спосіб імунокорекції при лікуванні загострень хронічних обструктивних захворювань легенів

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100104